Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Hidradenitis suppurativa improves with antiandrogen therapy.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Obese women with PCOS are more likely to have fatty liver disease.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Genetics and hormones cause hair loss; finasteride treats it safely.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Genetic variants in CYP genes may worsen PCOS symptoms.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Levothyroxine effectively treated a dog's skin and hair problems caused by hypothyroidism.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.